Senestech (SNES) & Its Competitors Head-To-Head Contrast

Senestech (NASDAQ:SNES – Get Free Report) is one of 296 publicly-traded companies in the “Chemicals” industry, but how does it compare to its peers? We will compare Senestech to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Profitability

This table compares Senestech and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Senestech -275.26% -98.70% -66.45%
Senestech Competitors -54.70% -0.39% -1.32%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Senestech and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senestech 1 0 0 0 1.00
Senestech Competitors 3282 12259 14171 521 2.39

As a group, “Chemicals” companies have a potential upside of 11.01%. Given Senestech’s peers stronger consensus rating and higher possible upside, analysts clearly believe Senestech has less favorable growth aspects than its peers.

Insider & Institutional Ownership

5.2% of Senestech shares are held by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are held by institutional investors. 2.2% of Senestech shares are held by company insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Senestech and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Senestech $2.22 million -$6.38 million -0.45
Senestech Competitors $6.36 billion $229.49 million 6.76

Senestech’s peers have higher revenue and earnings than Senestech. Senestech is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Senestech has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, Senestech’s peers have a beta of 0.94, indicating that their average share price is 6% less volatile than the S&P 500.

Summary

Senestech peers beat Senestech on 12 of the 12 factors compared.

Senestech Company Profile

(Get Free Report)

SenesTech, Inc. develops fertility-control products intended to help manage rodent populations. Its approach is designed to reduce reproduction rather than rely solely on conventional methods that remove rodents after they have become established. The company’s products include ContraPest, a liquid bait formulated to reduce fertility in rats, and Evolve, a soft-bait product for rodent population management. These products are intended for use in pest-control programs by professional customers and other organizations.

Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.